Sands Capital

true

Analysis for Life

Manufactures handheld mass spectroscopy instruments for chemical and biomolecular analysis for the field forensics and bioprocessing sectors.

Sands Capital first partnered with 908 Devices through its Series E round in April 2019. We assisted the company in securing investors for this round. Our team has continued to counsel management on forming strategic relationships and navigating the IPO process.

The case studies provided herein are a selection of investments that we believe illustrate our investment approach and philosophy, as well as the range of businesses in which Sands Capital typically invests. They were selected on an objective basis. The case studies are being provided for discussion purposes only and the information included should not be relied upon to make any investment decision. The full portfolio holdings are available here.

Related Insights

05.30.2023

Connecting Brands with Digital Content Creators

Read

Sands Capital consists of the combination of Sands Capital Management, LLC and Sands Capital Ventures, LLC. Sands Capital operates as a distinct business organization, retains discretion over the assets between the two registered investment advisers, and has autonomy over the total investment decision making process. The private markets investment strategies discussed herein are executed by Sands Capital Ventures with certain resources, including staff, provided by Sands Capital Management.

*AUM includes the discretionary and non-discretionary assets of Sands Capital Management, LLC, and the gross assets of all funds for Sands Capital Ventures, LLC rounded to the nearest billion. Private holdings valuations for Sands Capital Ventures are updated 45 to 60 days after quarter-end.

The information presented on this website is informational only and is not to be construed, by any means, to be an offering, solicitation, advertisement or marketing material to purchase securities or interests in any investment vehicle advised by Sands Capital. Such an offer will only be made by means of a Confidential Private Offering Memorandum, which will be available solely on request, on an exclusively private basis and only to qualified financially sophisticated investors, which contains important information (including investment objectives, policies, risk factors, fees, tax implications and relevant qualifications), and only in those jurisdictions where permitted by law.

Sands Capital
1000 Wilson Boulevard, Suite 3000
Arlington, Virginia 22209 USA
1.703.562.4000

Careers | Cookies | Privacy Policy | Terms & Conditions

Sands Capital is an active, long-term investor in leading innovative businesses globally. Our approach combines analytical rigor and creative thinking to identify high-quality growth businesses that are creating the future. Through an integrated investment platform spanning venture capital, growth equity, and public equity, we provide growth capital solutions to institutions and fund sponsors in more than 40 countries.

An independent, staff-owned firm founded in 1992 and headquartered in the Washington, D.C. area with offices in London and Singapore, Sands Capital managed more than $49B* in client assets as of March 31, 2025.